Bill of Lading
MFUSBL23137450
Product category
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
Product description
MEDICAMENTS CONTAINING ANTIGENS OR HYALURONICACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FO RM OR PACKED FOR RETAILMEDICAMENTS CONTAININGANTIGENS OR HYALURONIC ACID OR ITS SODIUM SA LT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE F ORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RET AILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGEFORM OR PACKED FOR RETAILMEDICAMENTS CONTAIN ING ANTIGENS OR HYALURONIC ACID OR ITS SODIUMSALT, NESOI, IN DOSAGE FORM OR PACKED FOR RE TAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAI NING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYAL URONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FORRETAILMEDICAMENTS CONTAINING ANTIGENS OR HYA LURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SO DIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAIL
Notify Party Name
Tahiti Transit
Notify Party Address
BP 310 PAPEETE 98713 PF
Arrival date
2023-08-28
Bill of lading
MFUSBL23137450
Master bill of lading
N/A
Hs code
300490
Shipment origin
Country of origin
FRANCE Port of loading
42737, LE HAVRESupplier name
MEDEXENO
Supplier address
9 RUE DU PONT VI LAT: 49 48454150 LNG: 0 15819790 LE HAVRE 76600 FR Place of receipt
LE HAVRE Shipment destination
Country of arrival
United States of America Port of arrival
1001, NEW YORK, NY Consignee name
Cerpol
Consignee address
BP 380584 PAPEETE 98718 PF Notify party address
BP 310 PAPEETE 98713 PF Carrier details
Vessel Name
Seatrade Green
Vessel code
9810915
Carrier SASC Code
MFUS, MARFRET
Vessel country
Liberia Voyage
3433
Container ID
TCLU8163466
Quantity
1130
Weight
9005 KG
TEU
1.5
CIF
N/A
Container size
4000*900*800